WellPoint Research Leads To Limits On Use Of Boniva; FDA Spars With Tobacco Company
Links shared publicly online about this topic.
- 1,061total visits
WellPoint Research Leads To Limits On Use Of Boniva; FDA Spars With Tobacco Company
View full resource at medicalnewstoday.com
Most Recently Shared on June 28, 2010 at 1:05 pm By:
WellPoint Research Leads To Limits On Use Of Boniva; FDA Spars With Tobacco Company http://mnt.to/3Frq #healthinsurance
Also Shared By:
WellPoint research leads to limits on use of Boniva; FDA spars with tobacco company
news-medical.net — “"WellPoint Inc. (WLP), the largest U.S. managed-care concern by membership, made it harder last year for its members to gain approval for use of the Boniva osteoporosis drug after internal research linked it to higher fracture rates, lower patient compliance and higher total costs of care than two other drugs, a WellPoint executive said Thursday," Dow Jones Newswires/The Wall Street Journal reports.” View full resource at news-medical.net
Most Recently Shared on June 28, 2010 at 9:27 am By:
WellPoint research leads to limits on use of Boniva; FDA spars with tobacco company: "WellPoint Inc. (WLP), the la... http://bit.ly/9RosXI
Advertisement
MNT Bones/Orthopedic
@mnt_bones
WellPoint Research Leads To Limits On Use Of Boniva; FDA Spars With Tobacco Company http://mnt.to/3Frq #bones #orthopedics
1 year ago...